Published in Am Heart J on November 01, 1979
Effects of combined alpha- and beta-blockade by labetalol in patients with coronary artery disease. Br J Clin Pharmacol (1982) 0.75
Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature (1991) 9.21
Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet (2001) 8.54
Life and death partners: apoptosis, autophagy and the cross-talk between them. Cell Death Differ (2009) 5.28
Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes. Cell Death Differ (2009) 3.44
Identification of a novel serine/threonine kinase and a novel 15-kD protein as potential mediators of the gamma interferon-induced cell death. Genes Dev (1995) 3.37
ICCE consensus for capsule retention. Endoscopy (2005) 2.98
AGA technical review on the evaluation and management of occult and obscure gastrointestinal bleeding. Gastroenterology (2000) 2.78
One-stage coronary angiography and angioplasty. Am J Cardiol (1995) 2.73
The death domain: a module shared by proteins with diverse cellular functions. Trends Biochem Sci (1995) 2.70
DAP-kinase is a Ca2+/calmodulin-dependent, cytoskeletal-associated protein kinase, with cell death-inducing functions that depend on its catalytic activity. EMBO J (1997) 2.69
Colonoscopy: a prospective report of complications. J Clin Gastroenterol (1992) 2.54
Close link between reduction of c-myc expression by interferon and, G0/G1 arrest. Nature (1985) 2.47
DAP kinase links the control of apoptosis to metastasis. Nature (1997) 2.39
Cathepsin D protease mediates programmed cell death induced by interferon-gamma, Fas/APO-1 and TNF-alpha. EMBO J (1996) 2.36
p53-mediated cell death: relationship to cell cycle control. Mol Cell Biol (1993) 2.27
DAP kinase activates a p19ARF/p53-mediated apoptotic checkpoint to suppress oncogenic transformation. Nat Cell Biol (2001) 2.09
Spontaneous pneumothorax and mitral valve prolapse. Chest (1986) 1.99
DAP-kinase is a mediator of endoplasmic reticulum stress-induced caspase activation and autophagic cell death. Cell Death Differ (2008) 1.99
Isolation of two interferon-induced translational inhibitors: a protein kinase and an oligo-isoadenylate synthetase. Proc Natl Acad Sci U S A (1978) 1.97
DAP-5, a novel homolog of eukaryotic translation initiation factor 4G isolated as a putative modulator of gamma interferon-induced programmed cell death. Mol Cell Biol (1997) 1.90
A genetic tool used to identify thioredoxin as a mediator of a growth inhibitory signal. Science (1991) 1.89
DAP-kinase participates in TNF-alpha- and Fas-induced apoptosis and its function requires the death domain. J Cell Biol (1999) 1.85
Histologic evidence for small-vessel coronary artery disease in patients with angina pectoris and patent large coronary arteries. Circulation (1986) 1.84
Development of a capsule endoscopy scoring index for small bowel mucosal inflammatory change. Aliment Pharmacol Ther (2007) 1.75
Autocrine beta-related interferon controls c-myc suppression and growth arrest during hematopoietic cell differentiation. Cell (1986) 1.73
A novel form of DAP5 protein accumulates in apoptotic cells as a result of caspase cleavage and internal ribosome entry site-mediated translation. Mol Cell Biol (2000) 1.72
Patient comprehension and reaction to participating in a double-blind randomized clinical trial (ISIS-4) in acute myocardial infarction. Arch Intern Med (2000) 1.69
Life-threatening hypotension after vasopressin injection during operative laparoscopy, followed by uneventful repeat laparoscopy. J Am Assoc Gynecol Laparosc (1994) 1.65
Linkages between deoxyribonucleic acid synthesis and cell division in Myxococcus xanthus. J Bacteriol (1976) 1.64
Push enteroscopic cauterization: long-term follow-up of 83 patients with bleeding small intestinal angiodysplasia. Gastrointest Endosc (1996) 1.62
The pro-apoptotic function of death-associated protein kinase is controlled by a unique inhibitory autophosphorylation-based mechanism. J Biol Chem (2001) 1.58
Kinetics of the induction of three translation-regulatory enzymes by interferon. Proc Natl Acad Sci U S A (1979) 1.56
Complementation by wild-type p53 of interleukin-6 effects on M1 cells: induction of cell cycle exit and cooperativity with c-myc suppression. Mol Cell Biol (1993) 1.56
The renal effect of low-dose dopamine in high-risk patients undergoing coronary angiography. J Am Coll Cardiol (1999) 1.53
Coronary pathology predicts conduction disturbances after coronary artery bypass grafting. Ann Thorac Surg (1991) 1.52
Long-term angiographic follow-up of coronary balloon angioplasty in patients with diabetes mellitus: a clue to the explanation of the results of the BARI study. Balloon Angioplasty Revascularization Investigation. J Am Coll Cardiol (1997) 1.47
The technique of abdominal pressure in total colonoscopy. Gastrointest Endosc (1991) 1.47
The interferon-induced protein kinase PK-i from mouse L cells. J Biol Chem (1979) 1.45
Stents in total occlusion for restenosis prevention. The multicentre randomized STOP study. The Israeli Working Group for Interventional Cardiology. Eur Heart J (2000) 1.44
Surgical approach to occult gastrointestinal bleeding. Am J Surg (1992) 1.42
Efficacy of hirudin in reducing cardiovascular events in patients with acute coronary syndrome undergoing early percutaneous coronary intervention. Eur Heart J (2002) 1.40
Partial resistance to anticoagulation after streptokinase treatment for acute myocardial infarction. Am J Cardiol (1990) 1.40
Pseudohypertension [correction of Pseudohypotension] in a patient with malignant hypertension. Isr Med Assoc J (2000) 1.39
Influence of coronary angioplasty on the progression of coronary atherosclerosis. Am J Cardiol (1995) 1.39
Perioperative myocardial ischemia in carotid endarterectomy under cervical plexus block and prophylactic nitroglycerin infusion. J Cardiothorac Vasc Anesth (1993) 1.39
"Congenital" coronary arteriovenous malformations: are they truly congenital? Cathet Cardiovasc Diagn (1996) 1.39
Improved outcome of coronary stenting by utilizing a modified treatment protocol. Isr J Med Sci (1996) 1.39
Death-associated protein kinase-related protein 1, a novel serine/threonine kinase involved in apoptosis. Mol Cell Biol (2000) 1.39
Systolic tricuspid leaflet prolapse in asymptomatic young men. Clin Cardiol (1989) 1.38
Left ventricular performance in septic shock: reversible segmental and global abnormalities. Am Heart J (1985) 1.38
Regulation of lymphocyte mitogenesis by (2'--5') oligo-isoadenylate. Nature (1980) 1.35
Generalized equations for predicting functional capacity from treadmill performance. Am Heart J (1984) 1.33
Autogenous production of interferon-beta switches on HLA genes during differentiation of histiocytic lymphoma U937 cells. EMBO J (1984) 1.31
Tumor necrosis factor reduces c-myc expression and cooperates with interferon-gamma in HeLa cells. Science (1986) 1.30
DAP-kinase loss of expression in various carcinoma and B-cell lymphoma cell lines: possible implications for role as tumor suppressor gene. Oncogene (1997) 1.29
Isolation of DAP3, a novel mediator of interferon-gamma-induced cell death. J Biol Chem (1995) 1.27
Antimitogenic effects of interferon and (2'-5')-oligoadenylate in synchronized 3T3 fibroblasts. FEBS Lett (1981) 1.26
Prehospital coronary thrombolysis. A new strategy in acute myocardial infarction. Chest (1987) 1.25
Rationale and design of ACTIVE: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events. Am Heart J (2006) 1.24
Effect of age and training on aerobic capacity and body composition of master athletes. J Appl Physiol (1985) (1987) 1.24
Interferons and interleukin 6 suppress phosphorylation of the retinoblastoma protein in growth-sensitive hematopoietic cells. Proc Natl Acad Sci U S A (1992) 1.24
DAP kinase-a proapoptotic gene that functions as a tumor suppressor. Exp Cell Res (2001) 1.22
Right atrial thrombi are related to indwelling central venous catheter position: insights into time course and possible mechanism of formation. Am Heart J (1998) 1.21
Initial characterization of a spontaneous interferon secreted during growth and differentiation of Friend erythroleukemia cells. Mol Cell Biol (1982) 1.21
New ways of initiating translation in eukaryotes. Mol Cell Biol (2001) 1.20
Anti-mitogenic function of interferon-induced (2'-5')oligo(adenylate) and growth-related variations in enzymes that synthesize and degrade this oligonucleotide. Eur J Biochem (1981) 1.18
DAP-kinase: from functional gene cloning to establishment of its role in apoptosis and cancer. Cell Death Differ (2001) 1.18
Interferons and interleukin-6 suppress the DNA-binding activity of E2F in growth-sensitive hematopoietic cells. Mol Cell Biol (1993) 1.16
DAP kinase regulates JNK signaling by binding and activating protein kinase D under oxidative stress. Cell Death Differ (2007) 1.16
DAP-kinase-mediated morphological changes are localization dependent and involve myosin-II phosphorylation. Cell Death Differ (2004) 1.14
PKD is a kinase of Vps34 that mediates ROS-induced autophagy downstream of DAPk. Cell Death Differ (2011) 1.13
Structure-function analysis of an evolutionary conserved protein, DAP3, which mediates TNF-alpha- and Fas-induced cell death. EMBO J (1999) 1.11
Echocardiographic diagnosis of unruptured sinus of Valsalva aneurysm. Am Heart J (1984) 1.10
Transradial approach for coronary angiography and angioplasty. Am J Cardiol (1995) 1.09
Assignment of DAP1 and DAPK--genes that positively mediate programmed cell death triggered by IFN-gamma--to chromosome regions 5p12.2 and 9q34.1, respectively. Genomics (1995) 1.09
An unusual case of mitral valve aneurysm: two dimensional echocardiographic and cineangiocardiographic features. Am J Cardiol (1982) 1.09
Posttransplant therapy using high-dose human immunoglobulin (intravenous gammaglobulin) to control acute humoral rejection in renal and cardiac allograft recipients and potential mechanism of action. Transplantation (1998) 1.07
Sectral in the management of angina pectoris. S Afr Med J (1973) 1.07
Long-term follow-up of the twisted ischemic adnexa managed by detorsion. Fertil Steril (1993) 1.07
Effectiveness of sectral (M & B 17803A) as a beta-blocking agent in man. S Afr Med J (1973) 1.04
Increased levels of interferon-induced (2'--5') oligo-isoadenylate synthetase in mature T-lymphocytes and in differentiated Friend-erythroleukemic cells. J Interferon Res (1981) 1.04
Right ventricular performance in septic shock: a combined radionuclide and hemodynamic study. J Am Coll Cardiol (1984) 1.03
Deregulated c-myc expression abrogates the interferon- and interleukin 6-mediated G0/G1 cell cycle arrest but not other inhibitory responses in M1 myeloblastic cells. Cell Growth Differ (1991) 1.03
DAP5 and IRES-mediated translation during programmed cell death. Cell Death Differ (2005) 1.03
High and low potency interferon-alpha subtypes induce (2'-5') oligoadenylate synthetase with similar efficiency. Virology (1983) 1.03
Death associated proteins (DAPs): from gene identification to the analysis of their apoptotic and tumor suppressive functions. Oncogene (1998) 1.03
Two-dimensional echocardiographic features of submitral left ventricular aneurysm. Am Heart J (1982) 1.03
A systems level strategy for analyzing the cell death network: implication in exploring the apoptosis/autophagy connection. Cell Death Differ (2010) 1.02
Small-bowel enteroscopy. Lancet (1991) 1.02
Alpha interferon suppresses the cyclin D3 and cdc25A genes, leading to a reversible G0-like arrest. Mol Cell Biol (1996) 1.02
Interferon-induced enzymes: microassays and their applications: purification and assay of (2'-5')-oligoadenylate synthetase and assay of 2'-phosphodiesterase. Methods Enzymol (1981) 1.02
Differential effects of two interferon-induced translational inhibitors on initiation of protein synthesis. Eur J Biochem (1979) 1.02
The autophagic inducer smARF interacts with and is stabilized by the mitochondrial p32 protein. Oncogene (2007) 1.02
Guide wire entrapment during PTCA: a potentially dangerous complication. Cathet Cardiovasc Diagn (1987) 1.02
Anomalous origin of the circumflex coronary artery from the right sinus of Valsalva as a cause of ischemia at old age. Clin Cardiol (1993) 1.01
Acute pulmonary oedema from sensitivity to beta-sympathetic blockade. S Afr Med J (1970) 1.00